Deccan Health Care
Healthcare Services
542248 BSE
₹12.00
Close ·
- P/E
- 11.76
Close 4 Nov 2026 ₹12.00 −4.95 −29.2% 1Y
Start ₹16.95
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures at the close · EPS basis: Consolidated · TTM
- ROCE
- 3.28%
- Debt to Equity
- 0.04
- EPS (TTM)
- ₹1.02
- Book Value
- ₹44.55
- Market Cap
- —
- P/E (TTM)
- 11.76
- P/B
- 0.27
- ROE
- 2.30%
- Dividend Yield
- 0.00%
- EBITDA
- ₹5.10 Cr
- 52W High
- ₹17.85
- 52W Low
- ₹6.65
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
50 Average
Data confidence 100/100
Category scores
- Quality
- 30
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 64
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 37
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 65
- Good
- Solvency, leverage, coverage 9% weight
- Momentum
- 45
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 48
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.29 times its book value
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 19.5%
- Company has a low return on equity of 1.72% over last 3 years.
- Contingent liabilities of Rs.18.7 Cr.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 6 | 1 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bearish
Bearish
2
Neutral
6
Bullish
1
Overall
Strong Bearish
Bearish
12
Neutral
6
Bullish
1
Moving Averages
Strong Bearish
Bearish
10
Neutral
0
Bullish
0
Key readings
- RSI (14)
- 46.43
- Neutral
- MACD (12,26,9)
- −0.06
- Bearish
- SMA (50)
- 12.34
- Bearish
- SMA (200)
- 12.58
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +18.95% |
|---|---|
| 3Y | +21.34% |
| 1Y | +7.15% |
| TTM | −0.37% |
Net profit
| 5Y | +44.89% |
|---|---|
| 3Y | +100.27% |
| 1Y | +114.66% |
| TTM | +145.63% |
Operating cash flow
| 5Y | Turned negative |
|---|---|
| 3Y | Outflow narrowed by ₹3.14 Cr |
| 1Y | Outflow narrowed by ₹2.81 Cr |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | +0.29 pp |
|---|---|
| 3Y | +1.98 pp |
| 1Y | +2.15 pp |
| TTM | +2.66 pp |
Revenue by year
| Mar 2020 | ₹42.24 Cr |
|---|---|
| Mar 2021 | ₹33.78 Cr |
| Mar 2022 | ₹33.17 Cr |
| Mar 2023 | ₹45.02 Cr |
| Mar 2024 | ₹59.73 Cr |
| Mar 2025 | ₹75.06 Cr |
| Mar 2026 | ₹80.43 Cr |
Net profit by year
| Mar 2020 | ₹10.09 Cr |
|---|---|
| Mar 2021 | ₹0.39 Cr |
| Mar 2022 | ₹0.32 Cr |
| Mar 2023 | ₹0.31 Cr |
| Mar 2024 | ₹1.49 Cr |
| Mar 2025 | ₹1.16 Cr |
| Mar 2026 | ₹2.49 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.22 | 17.19 | 15.34 | 15.97 | 15.06 | 18.82 | 20.43 | 20.75 | 22.14 | 21.4 | 17.39 | 20.98 | 22.07 |
| Expenses | 10.42 | 16.15 | 14.11 | 15.3 | 14.19 | 17.71 | 19.84 | 20.14 | 21.39 | 19.69 | 15.66 | 20.09 | 21.17 |
| Operating Profit | 0.8 | 1.04 | 1.23 | 0.67 | 0.87 | 1.11 | 0.59 | 0.61 | 0.75 | 1.71 | 1.73 | 0.89 | 0.9 |
| OPM % | 7.13% | 6.05% | 8.02% | 4.2% | 5.78% | 5.9% | 2.89% | 2.94% | 3.39% | 7.99% | 9.95% | 4.24% | 4.08% |
| Other Income | 0.01 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.03 |
| Interest | 0.02 | 0 | 0.04 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.16 | 0.04 | 0.14 | 0.16 |
| Depreciation | 0.39 | 0.32 | 0.4 | 0.36 | 0.36 | 0.37 | 0.37 | 0.36 | 0.41 | 0.33 | 0.35 | 0.38 | 0.39 |
| PBT | 0.4 | 0.72 | 0.79 | 0.3 | 0.49 | 0.71 | 0.2 | 0.23 | 0.33 | 1.22 | 1.34 | 0.37 | 0.38 |
| Tax % | 25% | 25% | 32.91% | 60% | 26.53% | 25.35% | 25% | 47.83% | 30.3% | 25.41% | 25.37% | 8.11% | 23.68% |
| Net Profit | 0.3 | 0.54 | 0.53 | 0.13 | 0.36 | 0.53 | 0.14 | 0.12 | 0.24 | 0.91 | 1 | 0.33 | 0.29 |
| EPS (₹) | 0.18 | 0.32 | 0.26 | 0.06 | 0.18 | 0.25 | 0.06 | 0.05 | 0.1 | 0.37 | 0.4 | 0.13 | 0.12 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.06 | 80.43 | 81.84 |
| Expenses | 30.57 | 31.74 | 27.54 | 43.06 | 55.97 | 71.92 | 75.34 | 76.61 |
| Operating Profit | 11.67 | 2.04 | 5.63 | 1.96 | 3.76 | 3.14 | 5.09 | 5.23 |
| OPM % | 27.63% | 6.04% | 16.97% | 4.35% | 6.29% | 4.18% | 6.33% | 6.39% |
| Other Income | 0.06 | 0.06 | −3.46 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 |
| Interest | 0.18 | 0.11 | 0.15 | 0.11 | 0.09 | 0.07 | 0.37 | 0.5 |
| Depreciation | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 | 1.46 | 1.45 |
| PBT | 10.13 | 0.52 | 0.55 | 0.44 | 2.21 | 1.63 | 3.27 | 3.31 |
| Tax % | 0.39% | 25% | 40% | 31.82% | 33.03% | 28.83% | 23.85% | — |
| Net Profit | 10.09 | 0.39 | 0.32 | 0.31 | 1.49 | 1.16 | 2.49 | 2.53 |
| EPS (₹) | 6.42 | 0.25 | 0.2 | 0.18 | 0.73 | 0.5 | 1.01 | 1.02 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 | 24.75 |
| Reserves | 60.52 | 60.91 | 61.23 | 64.52 | 76.53 | 82.97 | 85.51 |
| Borrowings | 0.87 | 1.03 | 1.25 | 1.61 | 1.9 | 1.15 | 3.96 |
| Other Liabilities | 15.89 | 14.61 | 12.44 | 13.62 | 9.24 | 17.38 | 34.69 |
| Total Liabilities | 92.99 | 92.26 | 90.63 | 96.79 | 108 | 125 | 149 |
| Fixed Assets | 21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | 15.02 |
| CWIP | 0 | 0.07 | 0 | 0 | 0 | 0 | 0 |
| Investments | 37.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 33.84 | 72.32 | 72.1 | 79.94 | 92.36 | 111 | 134 |
| Total Assets | 92.99 | 92.26 | 90.63 | 96.79 | 108 | 125 | 149 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 2.68 | 0.22 | −0.57 | −6.76 | −12.55 | −6.43 | −3.62 |
| Investing | −1.94 | −0.07 | −0.05 | 0.27 | −0.3 | −0.14 | −2.25 |
| Financing | −1.77 | −0.37 | 0.07 | 5.26 | 14.04 | 7.52 | 3.96 |
| Net Cash Flow | −1.03 | −0.22 | −0.56 | −1.23 | 1.19 | 0.95 | −1.91 |
| Free Cash Flow | 0.87 | 0.06 | −0.63 | −6.51 | −12.86 | −6.57 | −5.86 |
| CFO/EBITDA | 23 | 18 | −6 | −334 | −311 | −204 | −71 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 178 | 135 | 141 | 97.21 | 60.44 | 60.98 | 77.1 |
| Inventory Days | 0 | 891 | 1,183 | 684 | 445 | 327 | 340 |
| Days Payable | — | 112 | 148 | 123 | 41.68 | 69 | 143 |
| Cash Conversion Cycle | 178 | 913 | 1,176 | 658 | 464 | 319 | 274 |
| Working Capital Days | 422 | 546 | 603 | 508 | 477 | 423 | 427 |
| ROCE % | — | 0.81% | 5.62% | 0.68% | 2.53% | 1.65% | 3.28% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Deccan Health Care insights
60 extracted metrics across FY16–FY27.
Documents
- 14 Aug 2025
- General announcements 5 Oct 2026
Frequently Asked Questions about Deccan Health Care
What does Deccan Health Care Ltd do?
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products
Where is Deccan Health Care Ltd (DECCAN) listed?
Deccan Health Care Ltd trades under code 542248 on the BSE.
Which sector does Deccan Health Care Ltd belong to?
Deccan Health Care Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the PE ratio of Deccan Health Care Ltd?
Deccan Health Care Ltd trades at a PE ratio of 11.76 as of 4 Nov 2026, on earnings per share of ₹1.02, against a book value of ₹44.55 per share.
What is the 52-week high and low of Deccan Health Care Ltd?
Over the last 52 weeks Deccan Health Care Ltd has traded between ₹6.65 and ₹17.85 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Deccan Health Care Ltd?
Deccan Health Care Ltd reported a return on equity of 2.30%. Its debt-to-equity ratio is 0.04.
Company Information
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products
Website deccanhealthcare.co.in
CEO Dr. Minto Purshotam Gupta
Employees 83
Listed 31 Dec 2018
Face Value ₹10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542248.md for Deccan Health Care Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.